Interplay Between Systemic Inflammation, Myocardial Injury, and Coronary Microvascular Dysfunction in Rheumatoid Arthritis: Results From the LiiRA Study

Coronary microvascular dysfunction as measured by myocardial flow reserve (MFR) is associated with increased cardiovascular risk in rheumatoid arthritis (RA). The objective of this study was to determine the association between reducing inflammation with MFR and other measures of cardiovascular risk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Heart Association 2024-05, Vol.13 (9), p.e030387
Hauptverfasser: Weber, Brittany, Weisenfeld, Dana, Massarotti, Elena, Seyok, Thany, Cremone, Gabrielle, Lam, Ethan, Golnik, Charlotte, Brownmiller, Seth, Liu, Feng, Huang, Sicong, Todd, Derrick J, Coblyn, Jonathan S, Weinblatt, Michael E, Cai, Tianrun, Dahal, Kumar, Kohler, Minna, Yinh, Janeth, Barrett, Leanne, Solomon, Daniel H, Plutzky, Jorge, Schelbert, Heinrich R, Campisi, Roxana, Bolster, Marcy B, Di Carli, Marcelo, Liao, Katherine P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Coronary microvascular dysfunction as measured by myocardial flow reserve (MFR) is associated with increased cardiovascular risk in rheumatoid arthritis (RA). The objective of this study was to determine the association between reducing inflammation with MFR and other measures of cardiovascular risk. Patients with RA with active disease about to initiate a tumor necrosis factor inhibitor were enrolled (NCT02714881). All subjects underwent a cardiac perfusion positron emission tomography scan to quantify MFR at baseline before tumor necrosis factor inhibitor initiation, and after tumor necrosis factor inhibitor initiation at 24 weeks. MFR
ISSN:2047-9980
2047-9980
DOI:10.1161/JAHA.123.030387